NCT04374071View on ClinicalTrials.gov

Early Short Course Corticosteroids in COVID-19

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

March 12, 2020

Primary Completion Date

March 27, 2020

Study Completion Date

April 30, 2020

Conditions
COVIDPneumonia, Viral
Interventions
DRUG

Methylprednisolone

IV methylprednisolone 0.5 to 1 mg/kg/day in 2 divided doses for 3 days

Trial Locations (1)

48202

Henry Ford Hospital, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT04374071 - Early Short Course Corticosteroids in COVID-19 | Biotech Hunter | Biotech Hunter